SGLT2 gene expression in thirst‐promoting NOS1 neurons and vasopressin‐synthesizing neurons in male rats
Physiological Reports · 2026
DOI: 10.14814/phy2.71100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2026. Verfasst von Takahiro Masuda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan. Hauptthemen laut MEDLINE: Nitric Oxide Synthase Type I, Neurons, Thirst, Vasopressins. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KAKENHI grant from the Japan Society for the Promotion of Science, NIDDK NIH HHS, Foundation for the National Institutes of Health (FNIH).
Abstract (Originalsprache)
While sodium–glucose cotransporter 2 (SGLT2) inhibitors exert diuretic effects, they cause only mild changes in body fluid balance, partly through compensatory increases in water intake and vasopressin (AVP) secretion. However, whether SGLT2 inhibitors directly influence central pathways governing these fluid‐regulatory responses remains unclear. We here investigated Sglt2 expression in thirst‐regulating centers, the organum vasculosum of the lamina terminalis (OVLT) and subfornical organ (SFO) and hypothalamic AVP‐synthesizing regions, including the supraoptic nucleus (SON) and paraventricular nucleus (PVN). Droplet digital PCR analysis revealed Sglt2 expression in all regions, at levels comparable to angiotensin receptor 1a, a key regulator of drinking behavior. In situ hybridization confirmed Sglt2 mRNA signals in OVLT, SFO, SON, and PVN. Double in situ hybridization revealed that Sglt2 is co‐expressed in approximately 48%–60% of thirst‐promoting NOS1 neurons in the OVLT and SFO. Furthermore, Sglt2 was detected in over 80% of AVP‐synthesizing neurons and approximately 60% of oxytocin neurons within the SON and PVN. Our findings suggest that SGLT2 inhibitors have the potential to directly modulate central thirst and neuroendocrine responses, offering a novel anatomical framework for understanding their systemic effects on fluid balance and cardio‐renal protection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan.
- Division of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke, Tochigi, Japan.
- Division of Nephrology and Hypertension, Department of Medicine and Pharmacology, University of California San Diego and VA San Diego Healthcare System, San Diego, California, USA.
ORCID-Profile: Takahiro Masuda, Volker Vallon, Tatsushi Onaka
Förderung
- KAKENHI grant from the Japan Society for the Promotion of Science
- NIDDK NIH HHS
- Foundation for the National Institutes of Health (FNIH)
- Salt Science Research Foundation (SSRF)
- AMED-CREST
- the Manpei Suzuki Diabetes Foundation
Zitieren
APA
Masuda, T., Yoshida, M., Kim, Y. C., Vallon, V., Morishita, Y., Nagata, D., & Onaka, T. (2026). SGLT2 gene expression in thirst‐promoting NOS1 neurons and vasopressin‐synthesizing neurons in male rats. Physiological Reports. https://doi.org/10.14814/phy2.71100
Vancouver
Masuda T, Yoshida M, Kim YC, Vallon V, Morishita Y, Nagata D, et al. SGLT2 gene expression in thirst‐promoting NOS1 neurons and vasopressin‐synthesizing neurons in male rats. Physiological Reports. 2026. doi:10.14814/phy2.71100
BibTeX
@article{Masuda2026,
author = {Masuda, Takahiro and Yoshida, Masahide and Kim, Young Chul and Vallon, Volker and Morishita, Yoshiyuki and Nagata, Daisuke and Onaka, Tatsushi},
title = {SGLT2 gene expression in thirst‐promoting NOS1 neurons and vasopressin‐synthesizing neurons in male rats},
journal = {Physiological Reports},
year = {2026},
doi = {10.14814/phy2.71100}
}
EUVIMED